Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mamoru Tsukuda

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 11, 2006
[Clinical efficacy of administration with S-1 alone for head and neck carcinoma]Mamoru Tsukuda, Junichi Ishitoya, Yasukazu Mikami, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2003
Interleukin-13 receptor alpha2 chain in human head and neck cancer serves as a unique diagnostic markerMariko Kawakami, Koji Kawakami, Jan L Kasperbauer, et al.
International Journal of Oncology|February 21, 2012
Combined molecular targeted drug therapy for EGFR and HER-2 in head and neck squamous cell carcinoma cell linesNorio Kondo, Mamoru Tsukuda, Atsuko Sakakibara, et al.
Oncology Reports|March 6, 2010
Antitumor effects of lapatinib (GW572016), a dual inhibitor of EGFR and HER-2, in combination with cisplatin or paclitaxel on head and neck squamous cell carcinomaNorio Kondo, Mamoru Tsukuda, Yukari Ishiguro, et al.
Oncology Reports|January 1, 2010
Antitumor effects of telomelysin in combination with paclitaxel or cisplatin on head and neck squamous cell carcinomaNorio Kondo, Mamoru Tsukuda, Machiko Kimura, et al.
Japanese Journal of Clinical Oncology|November 26, 2009
Phase I/II study of s-1 plus cisplatin combination chemotherapy in patients with advanced/recurrent head and neck cancerMasato Fujii, Kitinobu Tomita, Wataru Nishijima, et al.
Oncology Reports|June 6, 2007
Anti-tumor effects of bevacizumab in combination with paclitaxel on head and neck squamous cell carcinomaKyoko Fujita, Daisuke Sano, Machiko Kimura, et al.
Oncology Reports|January 20, 2016
[Corrigendum] Antitumor effects of ZD6474 on head and neck squamous cell carcinomaDaisuke Sano, Mariko Kawakami, Kyoko Fujita, et al.
Acta Oto-Laryngologica|April 13, 2006
Concurrent chemoradiotherapy with cisplatin, 5-fluorouracil, methotrexate, and leucovorin in patients with advanced resectable squamous cell carcinoma of the larynx and hypopharynxTakahide Taguchi, Mamoru Tsukuda, Yasukazu Mikami, et al.
Clinical & Experimental Metastasis|January 28, 2005
Inostamycin suppresses vascular endothelial growth factor-stimulated growth and migration of human umbilical vein endothelial cellsYuh Baba, Yasumasa Kato, Izumi Mochimatsu, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 11, 2006
[Clinical efficacy of administration with S-1 alone for head and neck carcinoma]Mamoru Tsukuda, Junichi Ishitoya, Yasukazu Mikami, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2003
Interleukin-13 receptor alpha2 chain in human head and neck cancer serves as a unique diagnostic markerMariko Kawakami, Koji Kawakami, Jan L Kasperbauer, et al.
International Journal of Oncology|February 21, 2012
Combined molecular targeted drug therapy for EGFR and HER-2 in head and neck squamous cell carcinoma cell linesNorio Kondo, Mamoru Tsukuda, Atsuko Sakakibara, et al.
Oncology Reports|March 6, 2010
Antitumor effects of lapatinib (GW572016), a dual inhibitor of EGFR and HER-2, in combination with cisplatin or paclitaxel on head and neck squamous cell carcinomaNorio Kondo, Mamoru Tsukuda, Yukari Ishiguro, et al.
Oncology Reports|January 1, 2010
Antitumor effects of telomelysin in combination with paclitaxel or cisplatin on head and neck squamous cell carcinomaNorio Kondo, Mamoru Tsukuda, Machiko Kimura, et al.
Japanese Journal of Clinical Oncology|November 26, 2009
Phase I/II study of s-1 plus cisplatin combination chemotherapy in patients with advanced/recurrent head and neck cancerMasato Fujii, Kitinobu Tomita, Wataru Nishijima, et al.
Oncology Reports|June 6, 2007
Anti-tumor effects of bevacizumab in combination with paclitaxel on head and neck squamous cell carcinomaKyoko Fujita, Daisuke Sano, Machiko Kimura, et al.
Oncology Reports|January 20, 2016
[Corrigendum] Antitumor effects of ZD6474 on head and neck squamous cell carcinomaDaisuke Sano, Mariko Kawakami, Kyoko Fujita, et al.
Acta Oto-Laryngologica|April 13, 2006
Concurrent chemoradiotherapy with cisplatin, 5-fluorouracil, methotrexate, and leucovorin in patients with advanced resectable squamous cell carcinoma of the larynx and hypopharynxTakahide Taguchi, Mamoru Tsukuda, Yasukazu Mikami, et al.
Clinical & Experimental Metastasis|January 28, 2005
Inostamycin suppresses vascular endothelial growth factor-stimulated growth and migration of human umbilical vein endothelial cellsYuh Baba, Yasumasa Kato, Izumi Mochimatsu, et al.
Pageof 12